Drug Database
Back to search

Belgium· BE-AMP-SAM495511-00

Jetrea 0.375 mg/0.3 ml

A ocriplasmin product containing ocriplasmin, registered in Belgium by Inceptua. The same ATC class is registered in 4 of our 19 countries.

ATC S01XA22

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedJetrea 0.375 mg/0.3 mlATCS01XA22REGISTER NO.BE-AMP-SAM495511-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ocriplasminAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ocriplasmin is registered in 4 of 19 countries.

Countries holding a registration under ATC S01XA22 (ocriplasmin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 3 of them publish a price we can compare per daily dose
Search ocriplasmin products by name

Ocriplasmin · ATC S01XA22

4 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Polandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ocriplasmin
Manufacturer
Inceptua
Country
Belgium (BE)
ATC code
S01XA22
ATC class
Ocriplasmin
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    3756723

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ocriplasmin in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ocriplasmin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/61742be6-2c2f-4208-86e4-3d4b65df8ca6
GET /v1/drugs/61742be6-2c2f-4208-86e4-3d4b65df8ca6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Jetrea 0.375 mg/0.3 ml",
  "name_fr": "Jetrea 0.375 mg/0.3 ml",
  "name_nl": "Jetrea 0.375 mg/0.3 ml",
  "amp_code": "SAM495511-00",
  "strengths": [
    "1.2500",
    "1.2500"
  ],
  "pack_count": 1,
  "substances": [
    "Ocriplasmin",
    "Mannitol",
    "Sodium Chloride",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ocriplasmin",
  "authorisation_numbers": [
    "EU/1/13/819/002"
  ]
}
API referenceMCP serverPlans

See everything about ocriplasmin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console